Tunnelling nanotube formation is driven by Eps8/IRSp53‐dependent linear actin polymerization
The EMBO Journal · 2023
DOI: 10.15252/embj.2023113761 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von J Michael Henderson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Membrane Traffic and Pathogenesis Unit, Department of Cell Biology and Infection, CNRS UMR 3691, Université de Paris, Institut Pasteur, Paris, France. Hauptthemen laut MEDLINE: Actins, Nanotubes. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche (ANR), Centre National de la Recherche Scientifique (CNRS), Fondation pour la Recherche Médicale (FRM).
Abstract (Originalsprache)
Tunnelling nanotubes (TNTs) connect distant cells and mediate cargo transfer for intercellular communication in physiological and pathological contexts. How cells generate these actin‐mediated protrusions to span lengths beyond those attainable by canonical filopodia remains unknown. Through a combination of micropatterning, microscopy, and optical tweezer‐based approaches, we demonstrate that TNTs formed through the outward extension of actin achieve distances greater than the mean length of filopodia and that branched Arp2/3‐dependent pathways attenuate the extent to which actin polymerizes in nanotubes, thus limiting their occurrence. Proteomic analysis using epidermal growth factor receptor kinase substrate 8 (Eps8) as a positive effector of TNTs showed that, upon Arp2/3 inhibition, proteins enhancing filament turnover and depolymerization were reduced and Eps8 instead exhibited heightened interactions with the inverted Bin/Amphiphysin/Rvs (I‐BAR) domain protein IRSp53 that provides a direct connection with linear actin polymerases. Our data reveals how common protrusion players (Eps8 and IRSp53) form tunnelling nanotubes, and that when competing pathways overutilizing such proteins and monomeric actin in Arp2/3 networks are inhibited, processes promoting linear actin growth dominate to favour tunnelling nanotube formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Membrane Traffic and Pathogenesis Unit, Department of Cell Biology and Infection, CNRS UMR 3691, Université de Paris, Institut Pasteur, Paris, France.
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR 168, Laboratoire Physico-Chimie Curie, Paris, France.
- Sorbonne Université, Paris, France.
- Université Paris-Saclay, Gif-sur-Yvette, France.
- Proteomics Platform, Mass Spectrometry for Biology Unit, CNRS USR 2000, Institut Pasteur, Paris, France.
- Keele University, Keele, UK.
ORCID-Profile: J Michael Henderson, Sevan Belian, Thibault Chaze, Mariette Matondo, Patricia Bassereau, Chiara Zurzolo
Förderung
- Agence Nationale de la Recherche (ANR)
- Centre National de la Recherche Scientifique (CNRS)
- Fondation pour la Recherche Médicale (FRM)
- Pasteur Foundation (The Pasteur Foundation)
- Sorbonne Université (Sorbonne University)
Zitieren
APA
Henderson, J. M., Ljubojevic, N., Belian, S., Chaze, T., Castaneda, D., Battistella, A., Giai Gianetto, Q., Matondo, M., Descroix, S., Bassereau, P., & Zurzolo, C. (2023). Tunnelling nanotube formation is driven by Eps8/IRSp53‐dependent linear actin polymerization. The EMBO Journal. https://doi.org/10.15252/embj.2023113761
Vancouver
Henderson JM, Ljubojevic N, Belian S, Chaze T, Castaneda D, Battistella A, et al. Tunnelling nanotube formation is driven by Eps8/IRSp53‐dependent linear actin polymerization. The EMBO Journal. 2023. doi:10.15252/embj.2023113761
BibTeX
@article{Henderson2023,
author = {Henderson, J Michael and Ljubojevic, Nina and Belian, Sevan and Chaze, Thibault and Castaneda, Daryl and Battistella, Aude and Giai Gianetto, Quentin and Matondo, Mariette and Descroix, Stéphanie and Bassereau, Patricia and Zurzolo, Chiara},
title = {Tunnelling nanotube formation is driven by Eps8/IRSp53‐dependent linear actin polymerization},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2023113761}
}
EUVIMED